Srikumar Sen, Boxing Correspondent, Frances Gibb, Legal Affairs Correspondent, Andrew Billen, Patricia Davies, Jane MacQuitty, Simon Barnes, Mark Silversides, Peter Philp, Stephen Leather, Gordon Allan, Roland Rudd and Daniel Ward, Peter Lilley, Cliff Feltham, Shelia Gunn, Political Staff, Philip Howard, Michael Binyon, Jeremy Kingston, Jeremy Flint, Richard Streeton, Richard Eaton, Rory Howlett, Geoffrey Smith, John Bebb, Liz Smith, Fashion Editor, Geoff Brown, Colin Narbrough, Roddy Forsyth, Gerald Davies, Michael Seely Racing Correspondent, Howard Foster, Francesca Greenoak, Jim Railton, Jady Froshaug, J. R. Somons, Richard Shurey, Mohsin Ali, Richard Bassett and Dessa Tevisan, Rosemary Wells, John Ballantine, Lawrence Lever, Peter Waymark, Charles Jackson, Alan Hamilton, Andrew McEwen Diplomatic Correspodnent, Martin Cropper, Anne Barnes, MS, H. C. Robbins Landon, Peter Chambers, David Hands, Barry Fantoni, Clifford Longley Religions Affairs Editor, Charles Bremner, Edward Gorman, Martin Fletcher, Roland Rudd and Daniel Ward, Jenny Tabakoff, Walter Sinclair, Edward Fennell, Nicole Swengley, George Rae, Stephen Johnson, Sydney Friskin, Nicholas Harling, David Smith, Economics Correspondent, Chris Thau, Robert Matthews Technology Correspondent, Christopher Weatherley, John Higgins, Christopher Goulding, Anthony Bilmes, Raymond Keene, Alan Lee, Cricket Correspondent, Nicholas Beeston, Raymond Keene, Chess Correspondent, P. W., Nicholas Brett, Andrew McEwen, Diplomatic Correspondent, W. J. Burroughs, Roland Rudd, Stewart Tendler Crime Reporter, Richard Evans, Michael Ancram, Cathy Harris, Barry Pickthall, Irving Wardle, Roger Boyes, Peter Brimelow, Sheila A. Philbrook Chairman, Martin Fletcher and Daniel Ward, Francis Bissell, Ian Ross, Geoffrey Foster, Oliver Robinson, Brian Beel, Derek Harris, Industrial Editor, Keith MacKlin, David Hands Rugby Correspondent, David Walker Public Adminstration Correspondent, Kenneth Fleet, Christopher Thomas, Sarah Jane Art Market Correspondent, John Goodbody, John England, Scarman, Joy Melville, Hugh Richardson, Michael Hoarnsby, Eileen Morrison, Clive White, Robert Matthews, Technology Correspondent, Paul Newman, Alfred L. Curtis, Jane TAIT(Director), Jonathan Rendall, Michael Hornsby, David Gollob, Owen Jenkins, D. G. Roome, Peter Dear and Peter Davalle, Jeremy Swynnerton, Michael Clark and Geoffrey Foster, Peter Wilkinson, Graham Searjeant, David Sinclair, Andrew Buckoke, Stephen Pettitt, Tom Tickell, Peter Hankey, Jonathan Meades, Alan Tmilinson, Hartley Shawcross, Derek Harris Industrial Editor, Richard Wigg, Maria Scott, Michael Bnyon, Colin Campbell, Shona Crawford Poole, Jill Sherman, Social Services Correspodnent, VG, Nigel Andrews, Philip Ray, Richard Williams, Shelia Gunn and Nicholas Wood, John Cooney and David Sapsted,
... Theatre Concerts Bournemouth SO/Barshai Colston HAll, Bristol RAMSO/Henze Ram Recovery at Easter Theatre Holy Day ...
1988 - Gale Group | TDA
... VII, Part A. Lahore, Pakistan: Government Printing Press. Ramsø, Odd. 1968. Friendship. International Encyclopaedia of Social Sciences ( ...
Tópico(s): Philippine History and Culture
1986 - Wiley | Ethos
Anna Almén-Christensson, Mats Hammar, Lotta Lindh‐Åstrand, Anne‐Marie Landtblom, Jan Brynhildsen,
... recruiting patients and nurses/midwives Gunn Johansson, Christina Ramsö, and Lena Skaring-Thorssén for help with handling ...
Tópico(s): Ophthalmology and Eye Disorders
2011 - Elsevier BV | Fertility and Sterility
... a possible extension of the RAMSAS method (called RAMSoS) that is able to address the identified issues ...
Tópico(s): Safety Systems Engineering in Autonomy
2014 - Institute of Electrical and Electronics Engineers | IEEE Systems Journal
... var. capitata L.). The experiment included the cvs. Ramso and Copenhagen and the commercially available liquid fertilizers ...
Tópico(s): Growth and nutrition in plants
2017 - Taylor & Francis | International Journal of Vegetable Science
... Current jal, Dandi jal, Chandi jal, Poa jal, Ramsos jal, Ayre jal), Seine net (Ber jal), Fixed ... In the Dandi Jal, Poa Jal, Current Jal, Ramsos jal, Ayre Jal, Behundi Jal, Chargara Jal, Ber ... a particular species like chandi jal, poa jal, ramsos jal and ayre jal.Behundi Jal and Ber ...
Tópico(s): Metallurgy and Material Forming
2019 - | International Journal of Oceanography & Aquaculture
Diego Armesto, William M. Horspool, Nazario Martı́n, Ana Ramso, Carlos Seoane,
... Diego Armesto, William M. Horspool, Nazario Martin, Ana Ramso, and Carlos SeoaneCite this: J. Org. Chem. 1989, ...
Tópico(s): Chemistry and Chemical Engineering
1989 - American Chemical Society | The Journal of Organic Chemistry
Anders Faarbæk Mikkelstrup, Mathias Ramsø Thomsen, Kristoffer Stampe, Benny Endelt, J. Boll, Ewa Kristiansen, Morten Kristiansen,
The quality of robotic laser welded parts is related to the joint location, the trajectory of the laser focal point and the process parameters. By performing in-process monitoring, it is possible to acquire sufficient process knowledge for post-inspection to evaluate the geometrical weld quality. The existing solutions for such systems operate along linear welds. This paper contributes with a quality inspection system for robot laser welding, that can handle double-curved geometries. The data acquisition ...
Tópico(s): Welding Techniques and Residual Stresses
2019 - Elsevier BV | Procedia Manufacturing
Marina Konopleva, Tomasz Żal, Niki M. Zacharias, Byoung-Sik Cho, Karine G. Harutyunyan, Malgorzata Anna Zal, Hong Mu, Sergej Konoplev, Juliana Benito, Juliana Vélez, Carlos Bueso-Ramso, Jennifer R. Molina, Pratip K. Bhattacharya, Maria Emilia Di Francesco, Joseph R. Marszalek, Michael Andreeff,
... Sergej Konoplev, Juliana Benito, Juliana Velez, Carlos Bueso-Ramso, Jennifer Molina, Pratip K. Bhattacharya, Maria Emilia Di ...
Tópico(s): Hematological disorders and diagnostics
2015 - American Association for Cancer Research | Molecular Cancer Therapeutics
... such as Poa , Tengra, Ilish, Chewya, Golda chingri, Ramsos, Horina chingri, Kajli, Chapila, Motka chingri, Dogri, Boiragi ...
Tópico(s): Fish Ecology and Management Studies
2014 - IISTE | Journal of Biology Agriculture and Healthcare
Bjørn Anker Gjøl, Niels Valentin Jørgensen, Mathias Ramsø Thomsen, Luis Emilio Bruni,
It is a common assumption that subjects unconsciously construct storyworlds in their minds when experiencing a narrative. In this article we suggest that this construction includes imagined rules and constraints that if violated may affect the subjects’ suspension of disbelief. In this direction, we examine whether the cognitive processing of people experiencing interactive narratives varies based on whether the outcomes of their actions are perceived to be predictable and plausible, according to ...
Tópico(s): Narrative Theory and Analysis
2018 - Springer Science+Business Media | Lecture notes in computer science
Emil Ramsø Kyvsgaard, Morten Grauslund, Lene Dissing Sjö, Linea Cecilie Melchior, Trine Grantzau, Lise Mette Rahbek Gjerdrum, Trine Trab, Lena Andersen, Anne Ortved Gang, Marie Fredslund Breinholt, Michael Møller, Jacob Haaber Christensen, Thomas Stauffer Larsen, Michael Roost Clausen, Caroline Hasselbalch Riley, Carsten Utoft Niemann, Kirsten Grønbæk, Martin Hutchings, Simon Husby,
CD20 × CD3 bispecific antibodies such as glofitamab, epcoritamab, and mosunetuzumab are novel T cell engaging antibodies which have all shown convincing results and obtained FDA and EMA approval for the treatment of relapsed/refractory diffuse large B cell lymphomas (DLBCL) or follicular lymphoma (FL) with ≥ 2 prior lines of treatment [1]. However, approximately 50% of patients do not achieve remission when treated with single agent CD20 × CD3 bispecific antibodies. Subgroup analysis of pivotal phase I/II ...
Tópico(s): Lymphoma Diagnosis and Treatment
2025 - Wiley | American Journal of Hematology
Gloria Iacoboni, Emil Ramsø Kyvsgaard, Victor Navarro Garces, David A. Russler‐Germain, Alejandro Martı́n, Philip A. Thompson, Dylan Therwhanger, Itziar Carro, David Quintela, Pilar Gómez, Evelyn Valencia, Gala Vega, Ana Jiménez Ubieto, Mariana Bastos‐Oreiro, Ángel Serna, Simon Husby, Beatriz De La Cruz, Jing Luan, Sergi Camarillas, Lucía Medina, Almudena Cabero, Raúl Córdoba, Miguel Canales, Francesc Bosch, Juan‐Manuel Sancho, Anna Maria Sureda Balari, Stephen J. Schuster, Martin Hutchings, Pere Barba, Pau Abrisqueta Costa,
Tópico(s): Chronic Lymphocytic Leukemia Research
2024 - Elsevier BV | Blood
Emil Ramsø Kyvsgaard, Morten Grauslund, Lene Dissing Sjö, Linea Cecilie Melchior, Trine Grantzau, Lise Mette Rahbek Gjerdrum, Trine Trab, Lena Andersen, Anne Ortved Gang, Marie Fredslund Breinholt, Michael Møller, Jacob Haaber Christensen, Thomas Stauffer Larsen, Michael Roost Clausen, Anna Caroline Hasselbalch Riley, Carsten Utoft Niemann, Kirsten Grønbæk, Martin Hutchings, Simon Husby,
Tópico(s): Cell Adhesion Molecules Research
2024 - Elsevier BV | Blood
Emil Ramsø Kyvsgaard, Michael Roost Clausen, Anna Caroline Hasselbalch Riley, Carsten Utoft Niemann, Lene Dissing Sjö, Kirsten Grønbæk, Martin Hutchings, Simon Husby,
Introduction Several studies show that CD3xCD20 bispecific antibodies show promising results in relapsed or refractory B-cell lymphomas and may have a milder adverse effect profile compared to chimeric antigen receptor T cell therapy (CAR-T). Tumor loss of antibody target (i.e. CD19 or PD1) have shown to negatively affect treatment outcomes in CD19-CAR-T cell therapy in DLBCL, and anti-PD1 therapy in Hodgkin lymphoma. It has, to our knowledge, not been reported how loss of CD20 expression and other ...
Tópico(s): Monoclonal and Polyclonal Antibodies Research
2023 - Elsevier BV | Blood
Emil Ramsø Kyvsgaard, Michael Roost Clausen, Anna Caroline Hasselbalch Riley, Carsten Utoft Niemann, Kirsten Grønbæk, Martin Hutchings, Simon Husby,
Introduction: T-cell engaging CD3xCD20 bispecific antibodies like glofitamab, mosunetuzumab and epcoritamab are a new group of immunotherapies with promising results in B-cell lymphomas. T-cell engaging antibodies might have milder adverse effect profile compared to chimeric antigen receptor T-cell therapy (CAR-T). However, the duration of response to these new agents is still uncertain and follow-up times for glofitamab and epcoritamab have been short. We performed extensive follow-up of all patients ...
Tópico(s): Biosimilars and Bioanalytical Methods
2023 - Elsevier BV | Blood
Emil Ramsø Kyvsgaard, Caroline Hasselbalch Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten Utoft Niemann, Kirsten Grønbæk, Martin Hutchings, Simon Husby,
Patients with haematological malignancies and haematopoietic cell transplantation recipients are at increased risk of morbidity and mortality after COVID-19 infection.1-5 Patients treated with chimeric antigen receptor T-cell (CAR-T) therapy for B-cell malignancies have shown poor outcomes after COVID-19, both in case reports and retrospective multicentre studies, resulting in reported COVID-19 attributable mortality rates between 41% and 50%.5-8 A proposed explanation for these poor outcomes is ...
Tópico(s): COVID-19 Clinical Research Studies
2023 - Wiley | British Journal of Haematology
Emil Ramsø Kyvsgaard, Anna Caroline Hasselbalch Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten Utoft Niemann, Kirsten Grønbæk, Martin Hutchings, Simon Husby,
Introduction: Patients with hematological malignancies are at an increased risk of morbidity and mortality after COVID-19 infection.Especially patients treated with chimeric antigen receptor T-cell (CAR-T) therapy for B-cell malignancies have shown poor outcomes after COVID-19, resulting in reported COVID-19 attributable mortality rates between 41%-50%.Outcomes after COVID-19 infection in patients treated with CD20xCD3 bispecific antibodies have not been reported. We investigated the impact and clinical ...
Tópico(s): COVID-19 Clinical Research Studies
2023 - Elsevier BV | Blood
Emil Ramsø Kyvsgaard, Christopher B. Riley, Michael Roost Clausen, L. D. Heftdal, Carsten Utoft Niemann, K. Grønbæk, Martin Hutchings, Simon Husby,
Introduction: Patients with hematological malignancies are at an increased risk of morbidity and mortality from COVID-19. Especially patients treated with CAR-T cell therapy for B-cell malignancies have poor outcomes after COVID-19, with case mortality rates >40%. Outcomes of COVID-19 in patients treated with CD20xCD3 bispecific antibodies have not been reported. Methods: We identified all patients treated with bispecific antibodies in Denmark from December 2019 to December 2022. We collected data ...
Tópico(s): SARS-CoV-2 and COVID-19 Research
2023 - Wiley | Hematological Oncology